| |
| |
|
| Insider
Information: |
Smith Todd N |
| Relationship: |
President and CEO, Dir... |
| City: |
Northbrook |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, Chief Commercial ... |
2014-09-19 |
0 |
2012-12-10 |
0 |
Premium* |
|
|
Egalet Corp |
EGLT |
President and CEO, Dir... |
2020-05-20 |
0 |
2019-10-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGLT |
Egalet Corp |
President and CEO |
• • – |
2020-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(365,500) |
0 |
0 |
- |
|
| EGLT |
Egalet Corp |
President and CEO |
• • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
165,500 |
165,500 |
0 |
- |
|
| EGLT |
Egalet Corp |
President and CEO |
• • – |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2014-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
54,138 |
54,138 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
• – – |
2014-09-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,138) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2014-05-19 |
4 |
AS |
$12.94 |
$131,457 |
D/D |
(10,159) |
44,552 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2014-01-02 |
4/A |
OE |
$0.00 |
$0 |
D/D |
13,750 |
54,711 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2013-12-09 |
4 |
S |
$6.79 |
$78,276 |
D/D |
(11,322) |
40,961 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2013-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,350 |
52,283 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2013-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
18,037 |
48,933 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2013-01-02 |
4 |
AS |
$2.36 |
$16,515 |
D/D |
(6,998) |
22,570 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Commercial Officer |
• – – |
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
29,568 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
SVP, Marketing & Alliance Mgmt |
• – – |
2012-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,349 |
7,068 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
